Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience

Nienie Qi,Pengjie Wu,Jinchao Chen,Teng Li,Xianghui Ning,Jin Wang,Kan Gong

Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience

2017

Nienie Qi
Pengjie Wu
Jinchao Chen
Teng Li
Xianghui Ning
Jin Wang
Kan Gong

Background The aim of the study is to evaluate the role of cytoreductive nephrectomy (CN) with thrombectomy before targeted molecular therapy (TMT) on survival in metastatic renal cell carcinoma (mRCC) with venous tumor thrombus.

Keywords:

Targeted Molecular Therapy
Targeted therapy
Pathology
Single Center
Surgical oncology
Metastasis
Tumor thrombus
Medicine
Renal cell carcinoma
Nephrectomy
Survival analysis
Univariate analysis
Prognostic variable

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations